1. Home
  2. IPSC vs SPKL Comparison

IPSC vs SPKL Comparison

Compare IPSC & SPKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SPKL
  • Stock Information
  • Founded
  • IPSC 2019
  • SPKL 2021
  • Country
  • IPSC United States
  • SPKL United States
  • Employees
  • IPSC N/A
  • SPKL N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SPKL
  • Sector
  • IPSC Health Care
  • SPKL
  • Exchange
  • IPSC Nasdaq
  • SPKL Nasdaq
  • Market Cap
  • IPSC 149.1M
  • SPKL 172.9M
  • IPO Year
  • IPSC 2021
  • SPKL 2023
  • Fundamental
  • Price
  • IPSC $1.26
  • SPKL $10.61
  • Analyst Decision
  • IPSC Strong Buy
  • SPKL
  • Analyst Count
  • IPSC 4
  • SPKL 0
  • Target Price
  • IPSC $13.00
  • SPKL N/A
  • AVG Volume (30 Days)
  • IPSC 485.3K
  • SPKL 15.4K
  • Earning Date
  • IPSC 11-05-2024
  • SPKL 01-01-0001
  • Dividend Yield
  • IPSC N/A
  • SPKL N/A
  • EPS Growth
  • IPSC N/A
  • SPKL N/A
  • EPS
  • IPSC N/A
  • SPKL 0.19
  • Revenue
  • IPSC $2,684,000.00
  • SPKL N/A
  • Revenue This Year
  • IPSC $244.52
  • SPKL N/A
  • Revenue Next Year
  • IPSC $27.73
  • SPKL N/A
  • P/E Ratio
  • IPSC N/A
  • SPKL $57.07
  • Revenue Growth
  • IPSC 7.88
  • SPKL N/A
  • 52 Week Low
  • IPSC $1.14
  • SPKL $10.07
  • 52 Week High
  • IPSC $5.51
  • SPKL $11.95
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 41.15
  • SPKL 56.12
  • Support Level
  • IPSC $1.20
  • SPKL $10.54
  • Resistance Level
  • IPSC $1.50
  • SPKL $11.63
  • Average True Range (ATR)
  • IPSC 0.13
  • SPKL 0.35
  • MACD
  • IPSC -0.00
  • SPKL 0.00
  • Stochastic Oscillator
  • IPSC 24.45
  • SPKL 6.29

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About SPKL Spark I Acquisition Corp.

Spark I Acquisition Corp is a Blank check company.

Share on Social Networks: